Modern Surgery for Gastric Cancer — Japanese Perspective

Ajani JA Winter K Okawara GS Donohue JH Pister PWT Crane CH Greskovich JF Anne PR Bradley JD Willett C Rich TA : Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): Quality of combined modality therapy and pathologic response. J Clin Oncol 2006;24:3953–3958.

Gotoda T : A large endoscopic resection by endoscopic submucosal dissection procedure for early gastric cancer. Clinical Gastroenterol & Hepatol 2005;3(7 Suppl 1:S71–73.

Oda I Gotoda T Hamanaka H Eguchi T Saito Y Matsuda T Bhandari P Emura F Saito D Ono H : Endoscopic submucosal dissection for early gastric cancer: Technical feasibility, operation time and complications from a large consecutive series. Dig Endosc 2005;17:54–58.

Schlemper RJ Riddell RH Kato Y Borchard F Cooper HS Dawsey SM Dixon MF Fenoglio-Preiser CM Flejou J-F Geboes K Hattori T Hirota T Itabashi M Iwafuchi M Iwashita A Kim YI Kirchner T Klimpfinger M Koike M Lauwers GY Lewin KJ Oberhuber G Offiner F Price AB Rubio CA Shimizu M Shimoda T Sipponen P Solcia E Stolte M Waranabe H Yamabe H : The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251–255.

Binenkamp JJ Hermans J Sasako M van De Velde CJH For the Dutch Gastric Cancer Group. New Engl J Med 1999;340:908–914.

Cuschieri A Weeden S Fielding J Bancewicz J Craven J Joy-Paul V Sydes M Fayers P : Patient survival after D1 and D2 resection for gastric cancer: Long-term results of the MRC randomized surgical trial. Br J Cancer 1999;79:1522–1530.

Sano T Sasako M Yamamoto S Nashimoto A Kurita A Hiratsuka M Tsujinaka T Kinoshita T Arai K Yamamura Y Okajima K : Gastric cancer surgery: Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy — Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004;22:2767–2773.

Isozaki H Okajima K Fujii K : Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterol 46;1999:549–554.

Sasako M Sano T Yamamoto S Nashimoto A Kurita A Furukawa H Tsujinaka T Kinoshita T Arai K : Randomized phase III trial of standard D2 versus D2 + para-aortic lymph node dissection for clinically M0 advanced gastric cancer: JCOG 9501. J Clin Oncol 2006;24: 934s.

Nakajima T : Gastric Cancer Treatment Guideline in Japan. Gastric Cancer 2002;5:1–5.

Brennan MF : Lymph-node dissection for gastric cancer. N Engl J Med 1999;340:956–957.

Sasako M : Principles of surgical treatment for curable gastric cancer. J Clin Oncol 2003;23:274s–275s.

Hulscher JBF van Sandick JW De Boer AGEM Wijnhoven BPL Tijssen JGP Fockens P Stalmeier PFM ten Kate FJW van Dekken H Obertop H Tilanus HW van Lanschot JJB : Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662–1669.

Sasako M : Role of surgery in multidisciplinary treatment for solid cancers. Int J Clin Oncol 2004;9:346–351.

Degiuli M Sasako M Ponti A Soldati T Danese F Calvo F : Morbidity and mortality after D2 gastrectomy for gastric cancer: Results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 1998;16:1490–1493.

Roviello F Marrelli D Morgagni P De Manzoni G Di Leo A Vindigni C Saragoni L Tommezzoli A Kurihara H : Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: A longitudinal multicenter study. Ann Surg Oncol 2002;9:894–900.

Bunt AMG Hermans J Boon MC van de Velde CJH Sasako M Fleuren GJ Bruijn JA : Evaluation of the extent of lymphadenectomy in a randomized trial of Western — Versus Japanese-type surgery in gastric cancer. J Clin Oncol 1994;12:417–422.

Hundahl SA MacDonald JS Benedetti J Fitzsimmons T : Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment. Ann Surg Oncol 2002;9:278–286.

Peeters KCMJ Hundahl SA Kranenbarg EK Hartrink H van de Velde CJH : Low Maruyama index surgery for gastric cancer: Blinded reanalysis of the Dutch D1-D2 trial. World J Surg 2005;29:1576–1584.

Sasako M : Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 1997;84:1567–1571.

Wu CW Hsiung CA Lo SS Hsieh MC Chen JH Li AFY Lui WY Peng JW : Nodal dissection for patients with gastric cancer: A randomised controlled trial. Lancet Oncol 2006;309–315.

MacDonald JS Smalley SR Benedetti J Este SANC Stemmermann GN Haller DG Ajani JA Gunderson LL Jessup JM Martenson JA : Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725–730.

MacDonald JS : Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: Update of the results of Intergroup Study INT-0116 (SWOG 9008) (Virtual meeting of ASCO GI Symposium) Proc Am Soc Clin Oncol 19:1a, 2000.

Cunningham D Allum WH Stenning SP Thompson JN van de Velde CJH Nicolson M Scarffe JH Lofts FJ Falk SJ Iveson TJ Smith DB Langley RE Verma M Weeden S Cua YJ :Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20.

Ohtsu A Sasako M : Overview of adjuvant therapy for resected gastric cancer: Differences in Japan and the United States. Semin Oncol 2005;32:ss101–104.

Katai H Sano T Sasako M Fukagawa T Saka M : Update on surgery of gastric cancer: New procedures versus standard technique. Dig Surg 2004;22:338–344.

Sasako M Sano T Yamamoto S Sairenji M Arai K Kinoshita T Nashimoto A Hiratsuka M : Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: A randomised controlled trial. Lancet Oncol 2006;7:644–651.